Ties Between Medical Device Industry, Stent Doctors Questioned

Search

Topics

Uncategorized

Links
- FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of medical device:

Please describe any problems or injuries caused by the device:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Archives

Latest Medical Device News

20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP - Recall of one lot due to possible incorrect bar code for 5% Dextrose Injection, USP. The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication.
Gravity Compensating Accessory, High Pressure Range, Sterile, Single Use, by Integra NeuroSciences - Recall issued because the devices may leak cerebrospinal fluid which may cause inflammation of brain, spinal cord, or abdominal membranes, pressure on the wound created by implantation of the device, or failure of the shunt system.
Greenline-D MacIntosh No. 3 Laryngoscope Blades - Class 1 recall due to potential for piece of blade to break off during procedure.
Healon D Ophthalmic Viscosurgical Device - Recall of one lot of the product because some of the tested OVD syringes had endotoxin levels above the required limit.
Hydromorphone HCl 2 mg Tablets - Nationwide recall of a single lot due to potential for oversized tablets.
Innohep (tinzaparin sodium injection) - [UPDATE] Dear Healthcare Professional letter issued re: increased risk of death in elderly patients with renal insufficiency
October 2008 Safety Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription) - Reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products.
Stryker Custom Cranial Implant Kits - Class 1 recall because sterility cannot be assured.
Terumo Cardiovascular Systems Tenderflow Pediatric Arterial Cannulae - Worldwide recall involving 21 lot codes, due to reports of difficulty retracting the introducer from the cannula.
Weight Loss Pills - Products contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.

Ties Between Medical Device Industry, Stent Doctors Questioned

October 17th, 2008 laurie

The New York Times reports that heart doctors and makers of medical devices meeting for their annual Transcatheter Cardiovascular Therapeutics convention were made aware that two senators are asking tough questions about financial ties between the doctors and the companies.

The Times says lawmarkers Charles E. Grassley, Republican of Iowa, and Herb Kohl, Democrat of Wisconsin, sent a letter asking the nonprofit group that sponsors the conference, the Cardiovascular Research Foundation, for information about its financial relationships with device manufacturers and drug producers. The senators also sent a letter to Columbia University, which has an affiliation with the Cardiovascular Research Foundation. Two well-known researchers at Columbia, Dr. Martin B. Leon and Dr. Gregg W. Stone, are involved with the foundation; Dr. Leon is its former chairman and Dr. Stone its current one.

In their letter to the foundation, the lawmakers also took note of a comment in an article published last November in The New York Times. In the article, a researcher, Dr. Jeffrey W. Moses, who serves on the board of the Cardiovascular Research Foundation, said that the safety of heart stents “is not the big issue any more.”

The senators wrote: “As you are no doubt aware, there are divergent scientific opinions concerning such products, the safety and efficacy of which are a matter of dispute among cardiologists.”

The letter to the Cardiovascular Research Foundation asked the group to disclose all financing it had received since 2003 from the five device manufacturers named in the letter and also to provide documentation of any payments and benefits the foundation had provided to 22 researchers including Dr. Stone, Dr. Leon and Dr. Moses. The lawmakers asked Columbia to provide information about the disclosures those researchers had made to the institution about their income from industry sources.

At the same conference on Thursday, researchers released results of a new study indicating that a drug-coated stent called Endeavor, made by Medtronic, was linked to more heart attacks and deadly blood clots than the Cypher stent made by Johnson & Johnson.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.